Archive for July 2013

Evolution of a memory drug for Down’s syndrome

A couple of months ago I broke a story for New Scientist about clinical trials of the first drug specifically designed to tackle learning impairment in Down’s syndrome. It was published online on 11th April, and a cut down version appeared in the magazine’s InBrief section on the 20th ( pdf available on request). But… (read more)